Evidence map›Paper›PMID 26253701›Full record

ArticleClinical and experimental medicine2016

CD3

Carmen Lara-Rodríguez, Noé Alvarado-Vásquez, Demetrio Bernal, Patricia Gorocica, Edgar Zenteno, Ricardo Lascuraín

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Carmen Lara-RodríguezDepartment of Biochemistry, Faculty of Medicine, UNAM, Mexico D.F., Mexico. mlara@ujsierra.com.mx.
Noé Alvarado-VásquezDepartment of Biochemistry, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Mexico D.F., Mexico.
Demetrio BernalDepartment of Biochemistry, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Mexico D.F., Mexico.
Patricia GorocicaDepartment of Biochemistry, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Mexico D.F., Mexico.
Edgar ZentenoDepartment of Biochemistry, Faculty of Medicine, UNAM, Mexico D.F., Mexico.
Ricardo LascuraínDepartment of Biochemistry, Faculty of Medicine, UNAM, Mexico D.F., Mexico.
Instituto Nacional de Enfermedades Respiratorias · MXUniversidad Nacional Autónoma de México · MXUniversidad de la Sierra Juárez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence indicates that more than 90 % of infected individuals never develop active tuberculosis. This fact highlights the relevance of the immune response in tuberculosis control. The inducible co-stimulator (ICOS) is a regulator of the function, differentiation, proliferation, and activation of T cells. Moreover, T cells synthesise nitric oxide (NO), interferon gamma (IFN-γ), and interleukin (IL)-10, which help regulate the immune response to tuberculosis. Therefore, we assessed the synthesis of NO, IFN-γ, and IL-10 in CD3

Indexed as

AdultCD3 ComplexCells, CulturedFamilyFemaleHealthy VolunteersHumansHydrolasesInducible T-Cell Co-Stimulator ProteinInterferon-gammaInterleukin-10Lymphocyte ActivationMaleNitric OxideT-LymphocytesTuberculosis, PulmonaryCD3 ComplexHsaD protein, Mycobacterium tuberculosisHydrolasesICOS protein, humanIFNG protein, humanIL10 protein, humanInducible T-Cell Co-Stimulator ProteinInterferon-gammaInterleukin-10Nitric OxideHealthy house contactsInducible co-stimulator moleculeInterleukinsMitochondriaNitric oxidePulmonary tuberculosisT cells

Identifiers

PMID26253701
OpenAlexW1870391773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.